Analysts think SMLR stock price could increase by 19%
Jul 31, 2024, 6:26 AM
-20.20%
What does SMLR do
Semler Scientific, Inc., based in Santa Clara, California, specializes in technology and software solutions like QuantaFlo, a test for diagnosing peripheral arterial disease, and Insulin Insights for managing Type 2 diabetes. Founded in 2014, the company serves insurance plans, physician groups, and employs 127 people, focusing on products that evaluate and treat chronic diseases.
3 analysts think SMLR stock price will increase by 19.02%. The current median analyst target is $40.80 compared to a current stock price of $34.28. The lowest analysts target is $40.40 and the highest analyst target is $42.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
